Molecular classification of hepatocellular carcinoma: potential therapeutic implications.
about
Serum Wisteria Floribunda Agglutinin-Positive Sialylated Mucin 1 as a Marker of Progenitor/Biliary Features in Hepatocellular Carcinoma.Clinicopathological indices to predict hepatocellular carcinoma molecular classificationHepatitis-Associated Liver Cancer: Gaps and Opportunities to Improve Care.Biomarker MicroRNAs for Diagnosis, Prognosis and Treatment of Hepatocellular Carcinoma: A Functional Survey and Comparison.Overexpression of dishevelled 2 is involved in tumor metastasis and is associated with poor prognosis in hepatocellular carcinoma.Quantification of hepatocellular carcinoma heterogeneity with multiparametric magnetic resonance imagingGenome-wide association analysis identifies a GLUL haplotype for familial hepatitis B virus-related hepatocellular carcinoma.Imaging Hepatocellular Carcinoma With 68Ga-Citrate PET: First Clinical Experience.Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells.Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine.Deep Learning based multi-omics integration robustly predicts survival in liver cancer.In vitro modeling of hepatocellular carcinoma molecular subtypes for anti-cancer drug assessment.Genomic Analysis Revealed New Oncogenic Signatures in TP53-Mutant Hepatocellular Carcinoma.Gadoxetic acid-enhanced magnetic resonance imaging reflects co-activation of β-catenin and hepatocyte nuclear factor 4α in hepatocellular carcinoma.Imaging-based surrogate markers of transcriptome subclasses and signatures in hepatocellular carcinoma: preliminary results.Molecular heterogeneity in hepatocellular carcinoma
P2860
Q33670826-62A595E9-8FCE-45A7-B188-3430D98ABD83Q36359814-EB021877-553B-48E2-A9FA-717E3326F00AQ36871021-925636C4-0D6B-4701-9353-41CC82C27419Q37472263-9BD9DFE3-1FDE-441E-A99C-6182C8AC216BQ38739157-28993E9E-8235-44D4-9C90-DE087DCA2267Q38760629-A968D9CC-112D-4D95-9028-291E2DB9F07FQ40141021-506B38E2-613E-4168-9A6A-D7D06BA51A56Q41078929-B11AA0BE-B442-4300-91B0-C19B857ADB31Q41670848-E583BAE2-40C9-4777-B0FB-7DCF5A5BE4CDQ41921861-182C63A4-FB16-4A76-A896-871638BDF9DCQ47855807-31AC6807-D443-439E-9B4C-3AF5AE701300Q48304356-DBF316A8-49B8-46B5-A2AC-315C6ACB2956Q49884832-E4C7577F-BC7B-4A83-B265-A0613A579DA8Q50207765-9687E103-F916-4D9B-9A8E-C8DE86EE430AQ53839990-07981757-B6B5-4258-97AA-744CAD558B71Q57300487-02040496-AD9F-48E7-B1BD-A67E36A19B14
P2860
Molecular classification of hepatocellular carcinoma: potential therapeutic implications.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Molecular classification of hepatocellular carcinoma: potential therapeutic implications.
@en
Molecular classification of hepatocellular carcinoma: potential therapeutic implications.
@nl
type
label
Molecular classification of hepatocellular carcinoma: potential therapeutic implications.
@en
Molecular classification of hepatocellular carcinoma: potential therapeutic implications.
@nl
prefLabel
Molecular classification of hepatocellular carcinoma: potential therapeutic implications.
@en
Molecular classification of hepatocellular carcinoma: potential therapeutic implications.
@nl
P2093
P2860
P356
P1433
P1476
Molecular classification of hepatocellular carcinoma: potential therapeutic implications.
@en
P2093
Nicolas Goossens
Xiaochen Sun
Yujin Hoshida
P2860
P304
P356
10.2217/HEP.15.26
P577
2015-01-01T00:00:00Z